Literature DB >> 1736961

Antigenic and genomic relatedness among Ehrlichia risticii, Ehrlichia sennetsu, and Ehrlichia canis.

B Shankarappa1, S K Dutta, B L Mattingly-Napier.   

Abstract

Antigenic and genomic relatedness among Ehrlichia risticii, E. sennetsu, and E. canis was analyzed by enzyme-linked immunosorbent assay, Western blotting (immunoblotting) and DNA-DNA hybridization. E. risticii and E. sennetsu were serologically related, and their Western blot antigen profiles were nearly identical. Two antigens of E. sennetsu corresponding to the 28- and 51-kDa antigens of E. risticii were apparently larger than the E. risticii antigens, and the 55-kDa antigen of E. risticii appeared to be unique to this species. The 110-, 70-, and 44-kDa antigens of these two species were identical, as determined by the use of monospecific antibodies. DNA homology between these two species was high. On the other hand, E. canis was antigenically least reactive with the antisera to E. risticii and E. sennetsu. However, a dog convalescent-stage E. canis antiserum recognized antigens in the other two species which were different from those recognized by their homologous antisera. Similarly, homology between the DNA of E. canis and the DNAs of the other two species was very minimal. These results indicate that E. risticii and E. sennetsu are closely related both at the genomic and antigenic levels and that the relationship of these two species with E. canis is minimal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736961     DOI: 10.1099/00207713-42-1-127

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  9 in total

1.  Isolation of Ehrlichia chaffeensis from wild white-tailed deer (Odocoileus virginianus) confirms their role as natural reservoir hosts.

Authors:  J M Lockhart; W R Davidson; D E Stallknecht; J E Dawson; E W Howerth
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

2.  Proteomic analysis of Neorickettsia sennetsu surface-exposed proteins and porin activity of the major surface protein P51.

Authors:  Kathryn Gibson; Yumi Kumagai; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2010-09-10       Impact factor: 3.490

3.  Recombinant major antigenic protein 2 of Ehrlichia canis: a potential diagnostic tool.

Authors:  A R Alleman; L J McSherry; A F Barbet; E B Breitschwerdt; H L Sorenson; M V Bowie; M Bélanger
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  Genetic diversity of the 28-kilodalton outer membrane protein gene in human isolates of Ehrlichia chaffeensis.

Authors:  X J Yu; J W McBride; D H Walker
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

5.  Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia.

Authors:  J S Dumler; K M Asanovich; J S Bakken; P Richter; R Kimsey; J E Madigan
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

6.  Cultural, molecular, and immunological characterization of the etiologic agent for atypical canine ehrlichiosis.

Authors:  I Kakoma; R D Hansen; B E Anderson; T A Hanley; K G Sims; L Liu; C Bellamy; M T Long; B K Baek
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

7.  Serologic diagnosis of human monocytic ehrlichiosis by immunoblot analysis.

Authors:  P Brouqui; C Lecam; J Olson; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

8.  Serologic evidence for human ehrlichiosis in Africa.

Authors:  P Brouqui; C Le Cam; P J Kelly; R Laurens; A Tounkara; S Sawadogo; L Gondao; B Faugere; J Delmont
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

9.  Serological survey of Ehrlichia species in dogs, horses and humans: zoonotic scenery in a rural settlement from southern Brazil.

Authors:  Rafael Felipe da Costa Vieira; Thállitha Samih Wischral Jayme Vieira; Denise do Amaral Gomes Nascimento; Thiago F Martins; Felipe S Krawczak; Marcelo B Labruna; Ramaswamy Chandrashekar; Mary Marcondes; Alexander Welker Biondo; Odilon Vidotto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Sep-Oct       Impact factor: 1.846

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.